References
-
1
Ronkainen J A, Aro P, Storskrubb T. et al .
Prevalence of esophagitis and endoscopy-negative reflux disease in a population: a report from the Kalixanda study [abstract].
Gastroenterology.
2002;
122
A 213
-
2
Loftus C G, Haarewood G C, Romero Y. et al .
Declining diagnostic utility of upper endoscopy in patients with gastroesophageal reflux disease [abstract].
Gastrointest Endosc.
2002;
55
AB 89
-
3
Bretagne J F, Rey J F, Caekaert A. et al .
Observation of management of GERD in France by gastroenterologists: baseline data [abstract].
Gastroenterology.
2002;
122
A 584
-
4
Glenn T F, Wallace M B, Wildi S M. et al .
Screening for Barrett’s in an unselected GERD population with a nurse practitioner using a battery-powered endoscope (BPE) [abstract].
Gastrointest Endosc.
2002;
55
AB 200
-
5
Wildi S M, Wallace M B, Glenn T F. et al .
A comparison of diagnostic accuracy of esophagoscopy with a 4.0 mm battery-powered esophagoscope (BPE) by a nurse practitioner versus standard video-endoscopy (SVE) by a gastroenterologist [abstract].
Gastrointest Endosc.
2002;
55
AB 125
-
6
Catanzaro T, Faulx A L, Cooper G S. et al .
Narrow diameter esophagoscopy: 3 mm or 4 mm? Fiberoptic or video? [abstract].
Gastrointest Endosc.
2002;
55
AB 93
-
7
Herszenyi L, Dobronte Z, Velosy B. et al .
Comparison of Savary-Miller and Los Angeles classification of gastro-esophageal reflux disease: an interim analysis [abstract].
Gastroenterology.
2002;
122
A 582
-
8
Rath H C, Kunkel C, Endlicher E. et al .
Comparison of different scoring systems to classify reflux esophagitis [abstract].
Gastrointest Endosc.
2002;
55
AB 89
-
9
Massey B T.
Hill classification of the gastroesophageal junction: association with endoscopic findings of reflux disease [abstract].
Gastrointest Endosc.
2002;
55
AB 260
-
10
Tam W, Edebo A, Bruno M. et al .
Endoscopy-negative reflux disease (ENRD): high-resolution endoscopic and histological signs [abstract].
Gastroenterology.
2002;
122
A 74
-
11
Zentilin P, Baccini P, Mele M R. et al .
Re-evaluation of esophageal histology as a diagnostic tool in patient with GERD [abstract].
Gastroenterology.
2002;
122
A 581
-
12
Mason R J, DeMeester T, Banki F. et al .
Postprandial gastroesophageal reflux after a standardized meal: a sensitive measurement for early reflux disease [abstract].
Gastrointest Endosc.
2002;
55
AB 258
-
13
Waite B K, Palmer R A, Taylor A J. et al .
Intraesophageal reflux and intraesophageal stasis are distinct from gastroesophageal reflux as seen radiographically [abstract].
Gastrointest Endosc.
2002;
55
AB 257
-
14
Chen Y K, Raijman I, Ben-Menachem T. et al .
One-year follow-up of endoluminal gastroplication (ELGP): clinical and economic outcomes of the U.S. multicenter trial [abstract].
Gastrointest Endosc.
2002;
55
AB 109
-
15
Raijman I.
Helical endoluminal gastroplication (ELGP): assessment of esophageal function before and after procedure [abstract].
Gastrointest Endosc.
2002;
55
AB 261
-
16
Raijman I, Ben-Menachem T, Starpoli A A. et al .
Endoluminal gastroplication (ELGP) improves GERD symptoms in patients with large hiatal hernias [abstract].
Gastrointest Endosc.
2002;
55
AB 255
-
17
Liu J J, Knapp R, Silk J. et al .
Treatment of medication refractory gastroesophageal reflux disease with endoluminal gastroplication [abstract].
Gastrointest Endosc.
2002;
55
AB 257
-
18
Abou-Rebyeh H, Hoepffner N, Osmanoglu E. et al .
Endoscopic suturing is able to reduce pathological acid reflux in gastro-esophageal reflux disease [abstract].
Gastrointest Endosc.
2002;
55
AB 259
-
19
Caca K, Schiefke I, Söder H. et al .
Endoluminal gastroplication for gastroesophageal reflux disease [abstract].
Gastrointest Endosc.
2002;
55
AB 110
-
20
Arts J, Slootmakers S, Sifrim D. et al .
Endoluminal gastroplication (Endocinch) in GERD patients refractory to PPI therapy [abstract].
Gastroenterology.
2002;
122
A 47-A 48
-
21
Mansell D E.
Extended follow-up in patients treated with the Stretta procedure: a report on 29 patients [abstract].
Gastrointest Endosc.
2002;
55
AB 194
-
22
Liu J J, Knapp R M, Carr-Locke D L.
The impact of anesthesiologist’s experience on endoluminal gastroplication (ELGP) [abstract].
Gastrointest Endosc.
2002;
55
AB 119
-
23
Mahmood Z, Byrne P J, McCullough J. et al .
A comparison of Bard Endocinch transesophageal endoscopic plication (BETEP) with laparoscopic Nissen fundoplication (LNF) for the treatment of gastroesophageal reflux disease (GERD) [abstract].
Gastrointest Endosc.
2002;
55
AB 90
-
24
Spechler S J, Lee E, Ahnen D. et al .
Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial.
JAMA.
2001;
285
2331-2338
-
25
Lundell L, Miettinen P, Myrvold H E. et al .
Continued (5-year) follow-up of a randomized clinical study comparing antireflux surgery and omeprazole in gastroesophageal reflux disease.
J Am Coll Surg.
2001;
192
172-179
-
26
Feitoza A B, Gostout C J, Burgart L J. et al .
Understanding endoluminal gastroplications: a histopathologic analysis of intraluminal suture plications [abstract].
Gastrointest Endosc.
2002;
55
AB 255
-
27
Lehman G A, Dunne D P, Hieston K. et al .
Suturing plication of cardia with Endocinch device - effect of supplemental cautery: a human prospective randomized trial [abstract].
Gastrointest Endosc.
2002;
55
AB 260
-
28
Raijman I, Walters R, Garza C. et al .
Helical endoluminal gastroplication (ELGP) compared with standard ELGP in patients with gastroesophageal reflux disease (GERD) [abstract].
Gastrointest Endosc.
2002;
55
AB 260
-
29
Noar M D, Knight S, Bidlack D.
Long term experience with the Stretta procedure in medically refractory GERD patients: the first 14 months [abstract].
Gastrointest Endosc.
2002;
55
AB 255
-
30
Mavrelis P, Mirro J, Hurwich D. et al .
Use of the Stretta procedure for the treatment of GERD: a community hospital experience [abstract].
Gastrointest Endosc.
2002;
55
AB 261
-
31
Tam W, Schoeman M, Dent J. et al .
Control of reflux following radiofrequency energy (RFE) treatment in patients with gastroesophageal reflux disease (GERD): 12 months’ follow-up [abstract].
Gastroenterology.
2002;
122
A 47
-
32
Tam W, Holloway R, Dent J. et al .
Impact of endoscopic suturing of the gastroesophageal junction on lower esophageal sphincter function and gastroesophageal reflux in patients with reflux disease [abstract].
Gastroenterology.
2002;
122
A 47
-
33
Wolfsen H C, Hemminger L L, Stark M E. et al .
Resource utilization and procedure parameters for the Stretta procedure: comparison with diagnostic endosonography [abstract].
Gastrointest Endosc.
2002;
55
AB 256
-
34
Wolfsen H.
Stretta procedure patient registry: gastroesophageal reflux disease (GERD) symptom scores, patient satisfaction and medication use in 590 patients [abstract].
Gastrointest Endosc.
2002;
55
AB 113
-
35
Noar M, Knight S, Bidlack D.
A modified technique for endoluminal delivery of radiofrequency (RF) energy (Stretta) for the treatment of GERD in patients with failed fundoplication or large hiatal hernia [abstract].
Gastrointest Endosc.
2002;
55
AB 258
-
36
Corley D A, Katz P, Wo J. et al .
Radiofrequency energy to the gastroesophageal junction for treatment of GERD (the Stretta procedure): a randomized, sham-controlled, multicenter clinical trial [abstract].
Gastrointest Endosc.
2002;
55
AB 100
-
37
Lehman G A, Aisenberg J, Cohen L B. et al .
Enteryx solution, a minimally invasive injectable treatment for GERD: international multicenter trial results [abstract].
Gastrointest Endosc.
2002;
55
AB 101
-
38
Lehman G A, Aisenberg J, Cohen L B. et al .
Improvement in esophageal pH probe studies after Enteryx therapy for GERD [abstract].
Gastrointest Endosc.
2002;
55
AB 89
-
39
Louis H, Voderholzer W, LeMoine O. et al .
Lower esophageal sphincter function after endoscopic polymer injection for GERD treatment: short-term results [abstract].
Gastroenterology.
2002;
122
A 188
-
40
Fockens P, Costamagna G, Gabbrielli A. et al .
Endoscopic augmentation of the lower esophageal sphincter (LES) for the treatment of GERD: multicenter study of the Gatekeeper reflux repair system [abstract].
Gastrointest Endosc.
2002;
55
AB 90
-
41
Fockens P, Bruno M J, Hirsch D P. et al .
Endoscopic augmentation of the lower esophageal sphincter: pilot study of the gatekeeper reflux repair system in patients with GERD [abstract].
Gastrointest Endosc.
2002;
55
AB 257
-
42
Fockens P, Bruno M J, Boeckxstaens G E. et al .
Endoscopic removal of the gatekeeper system prosthesis [abstract].
Gastrointest Endosc.
2002;
55
AB 260
-
43
Lehman G A, Watkin J L, Hieston K. et al .
Endoscopic gastroesophageal reflux disease (GERD) therapy with gatekeeper system: initiation of a multicenter prospective randomized trial [abstract].
Gastrointest Endosc.
2002;
55
AB 261
-
44
Chuttani R, Sud R, Sachdev G. et al .
Endoscopic full thickness plication for GERD: final results of human pilot study [abstract].
Gastrointest Endosc.
2002;
55
AB 258
-
45
Pasricha P J, Yusuf T, Deyo D. et al .
Endoscopic valvuloplasty in a live animal model using a prototype anti-reflux device: the His-Wiz [abstract].
Gastrointest Endosc.
2002;
55
AB 259
-
46
Godin N.
The GARD (gastro-esophageal anti-reflux device) for GERD - an office procedure: preliminary report [abstract].
Gastrointest Endosc.
2002;
55
AB 261
-
47
Weinstein W M, Leh W, Lewin K. et al .
How often is short-segment Barrett’s esophagus proven histologically? A prospective study [abstract].
Gastroenterology.
2002;
122
A 293
-
48
Meining A, Ott R, Werner M. et al .
What predicts goblet cell metaplasia at the esophagogastric junction? [abstract].
Gastrointest Endosc.
2002;
55
AB 201
-
49
Endlicher E, Ruemmele P, Beer S. et al .
Endoscopic and histologic diagnosis of long and short Barrett’s esophagus [abstract].
Gastrointest Endosc.
2002;
55
AB 203
-
50
Seitz G, Vieth M, Stolte M.
Does endoscopically negative Barrett’s mucosa really exist? [abstract].
Gastrointest Endosc.
2002;
55
AB 203
-
51
Seitz G, Stolte M, Vieth M.
Barrett’s mucosa or intestinal metaplasia of cardia mucosa: a prospective study in 1000 patients [abstract].
Gastrointest Endosc.
2002;
55
AB 200
-
52
Gerson L B, Fass R, Fullerton H. et al .
Prospective assessment of a symptom questionnaire to predict Barrett’s esophagus in patients with gastroesophageal reflux disease [abstract].
Gastrointest Endosc.
2002;
55
AB 93
-
53
Tam W, Ruskiewicz A, Dent J. et al .
High-resolution magnification chromoendoscopy of esophageal specialized intestinal metaplasia with crystal violet [abstract].
Gastroenterology.
2002;
122
A 294
-
54
Park S H, Lee T K, Kim J I. et al .
Comparison of iodine directed biopsies and conventional metaplasia in Barrett’s esophagus [abstract].
Gastrointest Endosc.
2002;
55
AB 201
-
55
Cedillo-Ley I, Lopez-Acosta M E, Rodriguez-Vanegas G. et al .
Detection of short-segment Barrett’s esophagus using Lugol chromoendoscopy in patients with reflux symptoms [abstract].
Gastrointest Endosc.
2002;
55
AB 204
-
56
Rey J F, Lambert R.
A Barrett’s esophagus pattern classification [abstract].
Gastrointest Endosc.
2002;
55
AB 203
-
57
Schilling D, Rosenbaum A, Rebel M. et al .
Cytokeratin 7/20 immunoreactivity does not distinguish Barrett’s esophagus from gastric intestinal metaplasia [abstract].
Gastroenterology.
2002;
122
A 294
-
58
Going J J, Keith N W, Fletcher-Monaghan A J. et al .
Zonation of mucosal phenotype and telomerase activity in Barrett’s esophagus [abstract].
Gastroenterology.
2002;
122
A 289-A 290
-
59
Brotze S A, McElhinney C, Weston A. et al .
The prevalence of Barrett’s esophagus in patients with chronic gastro-esophageal reflux disease [abstract].
Gastrointest Endosc.
2002;
55
AB 203
-
60
Connor M J, Weston A, Mayo M S. et al .
Prevalence of BE and EE in patients undergoing endoscopy for dyspepsia [abstract].
Gastrointest Endosc.
2002;
55
AB 199
-
61
Faulx A L, Brock W E, Veri L. et al .
Unsedated esophagoscopy screening for Barrett’s esophagus (BE) in asymptomatic first-degree relatives [abstract].
Gastrointest Endosc.
2002;
55
AB 201
-
62
Brasseur C, Franchimont D P, Covas A. et al .
Development of Barrett’s esophagus after total gastrectomy [abstract].
Gastroenterology.
2002;
122
A 294
-
63
Dulai G S, Jensen D M, Chen J. et al .
Cancer risk, EGD biopsy workload and reporting in a population-based VA Barrett’s cohort [abstract].
Gastroenterology.
2002;
122
A 292
-
64
Campbell E, Eason A, Hamaad A. et al .
Has the risk of adenocarcinoma in Barrett’s esophagus been exaggerated? [abstract].
Gastroenterology.
2002;
122
A 292
-
65
Gerson L B, Triadafilopoulos G.
A cost-effectiveness analysis of screening for Barrett’s esophagus in patients with chronic gastroesophageal reflux disease [abstract].
Gastrointest Endosc.
2002;
55
AB 158
-
66
Inadomi J M, Sampliner R, Lagergren J. et al .
Cost-effectiveness of screening and surveillance for Barrett’s esophagus: more targeted screening, less surveillance [abstract].
Gastroenterology.
2002;
122
A 287-A 288
-
67
Provenzale D, Fisher D A.
Quality of life of Barrett’s patients enrolled in surveillance programs: implication for clinical decision-making [abstract].
Gastroenterology.
2002;
122
A 18
-
68
Tumbapura A P, Sandhu I S, Bjorkman D. et al .
Prevalence of hiatal hernia in patients with esophageal adenocarcinoma [abstract].
Gastrointest Endosc.
2002;
55
AB 225
-
69
Stuart R C, McKernan M, Neilson L. et al .
Endoscopic surveillance in Barrett’s esophagus: a structured biopsy protocol increases dysplasia detection [abstract].
Gastrointest Endosc.
2002;
55
AB 202
-
70
Sharma P, Falk G, Weston A. et al .
Natural history of low-grade dysplasia, an infrequent finding which usually regresses: preliminary results from the Barrett’s esophagus study [abstract].
Gastroenterology.
2002;
122
A 20
-
71
Kastrinos F, Banner B, Nompleggi D J.
Natural history of low-grade dysplasia in Barrett’s esophagus at a tertiary care medical center [abstract].
Gastroenterology.
2002;
122
A 294
-
72
Pacifico R, Wang K, Molckovsky A. et al .
Biopsy strategies in Barrett’s esophagus: which is the best for detecting high-grade dysplasia? [abstract].
Gastroenterology.
2002;
122
A 57
-
73
Dar M, Gramlich T, Richter J. et al .
Endoscopic brush cytology in Barrett’s esophagus surveillance: highly specific but less sensitive than previously reported [abstract].
Gastrointest Endosc.
2002;
55
AB 200
-
74
Lutzke L, Pacifico R, Wang K. et al .
Digital image analysis and brush cytology is better than cytology alone for detection of Barrett’s esophagus with high-grade dysplasia [abstract].
Gastroenterology.
2002;
122
A 289
-
75
Krishnadath S, Wang K, Halling K. et al .
Detection of cytogenetic abnormalities by multi-color FISH in brush cytology specimens of Barrett’s esophagus [abstract].
Gastroenterology.
2002;
122
A 289
-
76
Banerjee B, Chandrasekhar H R.
Selective use of a single autofluorescence emission ratio in Barrett’s esophagus [abstract].
Gastrointest Endosc.
2002;
55
AB 201
-
77
Skacel M, Gramlich T, Fahmy M. et al .
Fluorescence in-situ hybridization (FISH) of cytologic specimens from Barrett’s esophagus and adenocarcinoma: a pilot feasibility study [abstract].
Gastrointest Endosc.
2002;
55
AB 199
-
78
Brabender J, Marjoram P, Metzger R. et al .
A multigene expression panel for the molecular diagnosis of Barrett’s cancers [abstract].
Gastroenterology.
2002;
122
A 16-A 17
-
79
Mullick T, Tasch J E, Ormsby A H. et al .
High telomerase expression in Barrett’s esophagus without dysplasia predicts progression to esophageal adenocarcinoma [abstract].
Gastroenterology.
2002;
122
A 56-A 57
-
80
Wong Kee Song L M, Molckovsky A, Wang K. et al .
Raman spectroscopy for in vivo classification of Barrett’s tissue [abstract].
Gastroenterology.
2002;
122
A 288
-
81
Burdick S, Dykes C M, Lindberg G. et al .
Utilization of chromoendoscopy to identify dysplasia in Barrett’s esophagus [abstract].
Gastrointest Endosc.
2002;
55
AB 200
-
82
Gossner L, May A, Stolte M. et al .
Methylene blue staining for the detection of dysplasia or mucosal cancer in Barrett’s esophagus: a prospective trial [abstract].
Gastrointest Endosc.
2002;
55
AB 199
-
83
Ragunath K, Raman V S, Haqqani M. et al .
Methylene blue chromoendoscopy in Barrett’s oesophagus [abstract].
Gastroenterology.
2002;
122
A 289
-
84
Ortner M AE, Voderholzer W, Ebert B. et al .
Fluorescence imaging and white light endoscopy system with fluorescence spectroscopy are complementary methods in detecting malignant lesions in Barrett’s esophagus [abstract].
Gastroenterology.
2002;
122
A 31
-
85
Clarke A, Hilman L, Chiragakis L. et al .
Proton pump inhibitor therapy delays the development of dysplasia in patients with Barrett’s esophagus [abstract].
Gastroenterology.
2002;
122
A 293
-
86
Corey K E, Schmitz S M, Shaheen N J.
Does a surgical anti-reflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett’s esophagus? A meta-analysis [abstract].
Gastroenterology.
2002;
122
A 292
-
87
May A, Gossner L, Pech O. et al .
Acute-phase and long-term of local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett’s esophagus [abstract].
Gastroenterology.
2002;
122
A 287
-
88
Pacifico R, Wang K, Wong K ee. et al .
Endoscopic therapy versus esophagectomy for early stage Barrett’s adenocarcinoma [abstract].
Gastrointest Endosc.
2002;
55
AB 94
-
89
Hage M, van Dekken H, Vissers C J. et al .
Molecular evidence for complete reversal of Barrett’s esophagus with high-grade dysplasia following argon plasma coagulation alone or in combination with photodynamic therapy [abstract].
Gastrointest Endosc.
2002;
55
AB 206
-
90
Lee S K, Bhagat G, Memeo L. et al .
Endoscopic mucosal resection of polypoid lesions in Barrett’s esophagus [abstract].
Gastrointest Endosc.
2002;
55
AB 204
-
91
Giovannini M, Bories E, Monges G.
Treatment of high-grade dysplasia and in situ carcinoma on Barrett’s esophagus using endoscopic mucosal resection: results and outcomes in 22 patients [abstract].
Gastrointest Endosc.
2002;
55
AB 206
-
92
Deinert K, Schumacher B, Preiss C. et al .
Endoscopic mucosal resection cap procedure (EMCR) for early neoplastic Barrett’s esophagus [abstract].
Gastrointest Endosc.
2002;
55
AB 208
-
93
Bergman J J, Fockens P, van Lanschot J JB. et al .
Endoscopic mucosal resection (EMR) for intramucosal neoplasia in Barrett’s esophagus [abstract].
Gastrointest Endosc.
2002;
55
AB 206
-
94
Wang K, Wong K ee, Buttar N. et al .
Long-term follow-up after photodynamic therapy (PDT) for Barrett’s esophagus [abstract].
Gastrointest Endosc.
2002;
55
AB 100
-
95
Wolfsen H C.
Photodynamic therapy for dysplastic Barrett’s esophagus and mucosal esophageal adenocarcinoma [abstract].
Gastrointest Endosc.
2002;
55
AB 206
-
96
Beejay U, Christodoulou D, Rasul I. et al .
Photodynamic therapy of high-grade dysplasia/intramucosal carcinoma in Barrett’s esophagus: 38 months’ follow-up [abstract].
Gastrointest Endosc.
2002;
55
AB 208
-
97
Phan M N, Overholt B F, Panjehpour M. et al .
Photodynamic therapy for high grade dysplasia in Barrett’s esophagus using an improved light delivery balloon [abstract].
Gastroenterology.
2002;
122
A 351
-
98
Schembre D.
Photodynamic therapy for premalignant lesions of the esophagus: interim results of initial 26 cases [abstract].
Gastrointest Endosc.
2002;
55
AB 207
-
99
Jamieson N, Thorpe S, Bown S G. et al .
Optimizing of PDT for dysplastic Barrett’s esophagus remains a challenge [abstract].
Gastrointest Endosc.
2002;
55
AB 207
-
100
Michopoulos S, Sotiropoulou M, Petraki K. et al .
Long-term follow-up of Barrett’s esophagus after ablation with heat-probe [abstract].
Gastrointest Endosc.
2002;
55
AB 208
-
101
Dulai G S, Jensen D M, Weinstein W M. et al .
Randomized trial of APC vs. MPEC for ablation of Barrett’s esophagus [abstract].
Gastrointest Endosc.
2002;
55
AB 204
-
102
Enns R A, McDougall B, Kooner H. et al .
Prospective randomized trial of argon plasma coagulation versus multipolar electrocoagulation in the ablation of Barrett’s esophagus without dysplasia: preliminary results [abstract].
Gastrointest Endosc.
2002;
55
AB 94
-
103
Van de Vrie W, Hage M, Gabeler E EE. et al .
Endoscopic ablation of Barrett’s esophagus with photodynamic therapy and argon plasma coagulation: a dose-finding study [abstract].
Gastrointest Endosc.
2002;
55
AB 207
-
104
Seewald S, Brand B, Seitz U. et al .
Extensive and circumferential endoscopic mucosa resection as the management of high-grade dysplasia and intramucosal carcinoma in long-segment Barrett esophagus with nonvisible endoscopic lesion [abstract].
Gastrointest Endosc.
2002;
55
AB 205
-
105
May A, Gossner L, Behrens A. et al .
Suck and cut mucosectomy in early esophageal carcinomas - ligation device versus Inoue cap: a prospective comparison in 100 resections [abstract].
Gastrointest Endosc.
2002;
55
AB 113
-
106
Pacifico R, Wang K, Buttar N. et al .
Comparison of endoscopic mucosal resection techniques in Barrett’s esophagus [abstract].
Gastrointest Endosc.
2002;
55
AB 94
-
107
Hur C, Gazelle S, Nishioka N S.
Cost-effectiveness of photodynamic therapy for the treatment of Barrett’s esophagus with high-grade dysplasia [abstract].
Gastrointest Endosc.
2002;
55
AB 160
-
108
Stein H J, Feith M, Mueller J. et al .
Limited resection for early adenocarcinoma in Barrett’s esophagus.
Ann Surg.
2000;
232
733-742
-
109
Pinotti A, Maluf-Filho F, Cecconello I. et al .
Endoscopic ablation of Barrett’s esophagus using argon plasma coagulation (APC) after surgical treatment of reflux [abstract].
Gastrointest Endosc.
2002;
55
AB 208
-
110
Kelty C, Ackroyd R, Brown N. et al .
Photodynamic therapy (PDT) for Barrett’s esophagus: establishing the optimum dose 5-aminolevulinic acid (ALA) [abstract].
Gastrointest Endosc.
2002;
55
AB 204
-
111
Long P, Fuchs K, Freeman L. et al .
Esophageal healing following application of a novel bipolar electrocoagulation device [abstract].
Gastrointest Endosc.
2002;
55
AB 207
-
112
Fuchs K, Freeman L, Long P. et al .
A novel technique of esophageal mucosal ablation: comparison between a new bipolar device and argon plasma coagulation [abstract].
Gastrointest Endosc.
2002;
55
AB 205
-
113
Fleischer D E.
The Stretta procedure: technique optimization and complication rates [abstract].
Gastrointest Endosc.
2002;
55
AB 256
T. Rösch, M.D.
Deptartment of Internal Medicine II, Klinikum rechts der Isar, Technical University of Munich
Ismaningerstrasse 22 · 81675 Munich · Germany
Fax: + 49-89-4140-4872 ·
Email: Thomas.Roesch@lrz.tu-muenchen.de
